External Funding Opportunities

Funding Opportunity

Deadline

NIH Notice of Special Interest (NOSI): Research Supplements to Promote Re-Entry and Re-integration into Health-Related Research Careers (Admin Supp) Deadline: On-going starting August 26

Ongoing

NIH Integrating Biospecimen Science Approaches into Clinical Assay Development (U01)

January 11

NIH Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01)

February 5

NIH Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer  The purpose of this FOA is to support basic research that elucidates mechanisms by which the human microbiome inhibits or enhances anti-tumor immune responses, and to identify potential novel molecular targets for cancer prevention strategies.

  • R01 Deadline: February 5
  • R21 Deadline: February 16

 Varies

NIH Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01)

March 5

NIH Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33) 

April 22

NIH Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61)

April 22

NIH Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery  This FOA invites research projects that seek to explain the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in human health, illness, recovery, and overall wellbeing.

 June 21

 NIH Exploratory Grants in Cancer Control (R21)

 June 7

NIH Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity  The purpose of this Notice of Special Interest (NOSI) is to encourage collaborative and innovative approaches to mitigate cardiovascular dysfunction while optimizing cancer outcomes by understanding the mechanisms of cancer treatment-related cardiotoxicity and translating the findings to improve risk stratification, early detection, prevention, and management. Deadline: Depends on target FOA

 Varies

NIH Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards  The overarching goal of this pilot program is to enhance the retention of investigators facing critical life events who are transitioning to the first renewal of their first independent research project grant award or to a second new NIH research project grant award. Retention at the first renewal or continuous NIH research project grant support is crucial for sustaining both the ongoing research NIH has made an investment in and for retaining diversity in the biomedical research workforce. Deadline:  Varies by awarding IC

 Varies

NIH Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers  The purpose of this Notice of Special Interest (NOSI) is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals. Research efforts that identify specific contributions of HIV infection and its potential interaction with other pathogens towards the development and pathogenesis of these cancers and provide information on the clinical outcomes of such cancers in the HIV-infected population are sought.  Deadline:  Applies to due dates on or after May 7, 2020 through January 8, 2023

 Varies

NIH Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications  The purpose of this NOSI is to encouraging new applications to advance research activities relevant to synthetic biology.  The overarching goal(s) of this Notice are to: 1) develop tools and technologies to control and reprogram biological systems; 2) apply synthetic biology approaches for the development of biomedical technologies; 3) increase the fundamental understanding of synthetic biology concepts as they relate to human health; and 4) gain fundamental biological knowledge through the application of synthetic biology approaches. Deadline: Varies by IC

 Varies

NIH Research Supplements to Promote Diversity in Health-Related Research  The NIH and the CDC hereby notify PD(s)/PI(s) holding specific types of research grants  that funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project.  Administrative supplements must support work within the scope of the original project. Deadline: Varies by awarding IC

 Varies

NIH Notice of Special Interest (NOSI): Understanding the effects of cancer and cancer treatment on aging trajectories and aging outcomes  The purpose of this NOSI is to solicit investigator-initiated applications that aim to better understand the effects of a cancer diagnosis and subsequent cancer treatment on aging trajectories and aging outcomes. Applications for this initiative should submit through funding opportunity announcements (FOAs) or any reissues of these announcements as noted in this notice.

Varies

NIH Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health 

Varies

Funding Opportunity

Deadline

DOD-CDMRP Rare Cancers Research Program (RCRP)  The RCRP’s vision is to greatly improve outcomes for people with rare cancers through discovery, community building, and expansion of knowledge across the cancer landscape. The RCRP’s mission is to elevate rare cancers research to enable clinically impactful discoveries for the benefit of active-duty Service Members, Veterans, military beneficiaries, and/or the American public. Mechanisms include: Concept Award; Idea Development Award; and Resource and Community Development Award. Deadlines: July 13 – Pre-application; Varies – Application

Varies

DOD-CDMRP Pancreatic Cancer Research Program (PCARP)  The mission of the PCARP is to promote rigorous, innovative, high-impact research that leads to earlier pancreatic cancer diagnosis and new therapeutic tools through collaboration. Mechanisms include: Idea Development Award and Translational Research Partnership Award. Deadlines: July 1 – Pre-application; October 7 - Application

Varies

DOD-CDMRP Melanoma Research Program (MRP)  The vision of the MRP is to prevent melanoma initiation and progression. The MRP challenges the research community to prevent melanoma earlier in the disease cycle thus preventing metastasis. Mechanisms include: Academy Leadership Award, Idea Award, Mid-Career Accelerator Award, Academy Scholar Award, Translational Research Award, and Science Award. Deadlines: varies – Pre-application; September 28 - Application

Varies

DoD-CDMRP Breast Cancer Research Program  The BCRP challenges the scientific community to design research that will address the urgency of ending breast cancer. Specifically, the BCRP seeks to accelerate high-impact research with clinical relevance, encourage innovation and stimulate creativity, and facilitate productive collaborations. The following FY21 opportunities have been announced:

  • Breakthrough Award Levels 1 and 2  Letter of Intent due March 11; Application due March 25
  • Breakthrough Award Level 3  Preproposal due March 12; Invited application due June 23
  • Breakthrough Award Level 4  Preproposal due March 12; Invited application due June 23
  • Era of Hope Scholar Award  Letter of Intent due March 11; Application due March 25
  • Innovator Award  Preproposal due March 12; Application due June 23
  • Transformative Breast Cancer Consortium Award  Preproposal due March 12; Invited application due June 23
Varies

NSF Division of Molecular and Cellular Biosciences: Investigator-initiated research projects (MCB)  

On-going

DOE-JGI CSP New Investigator 

On-going

NSF Big Ideas updates

Varies

DOD-CDMRP FY21 Lung Cancer Research Program (LCRP)  The goal of the FY21 LCRP is to eradicate deaths and suffering from lung cancer to better the health and welfare of military Service members, Veterans, and the American public. As such, the LCRP will support and integrate research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, and treatment for the control and cure of lung cancer. Mechanisms include: Career Development Award and Concept Award. Deadlines: April 6 – Pre-application; April 20 - Application

Varies

DOD-CDMRP Ovarian Cancer Research Program (OCRP)  The mission of the OCRP is to support patient-centered research to prevent, detect, treat, and cure ovarian cancer to enhance the health and well-being of Service members, Veterans, their family members, and all women impacted by this disease. Mechanisms include: Clinical Translational Research Award, Investigator-Initiated Research Award, Academy Award, Pilot Award and Proteogenomics Research Award. Deadlines: April 1 – Pre-application; July 8 – Application

Varies

DOD-CDMRP Prostate Cancer Research Program (PCRP)  The PCRP seeks to promote highly innovative, groundbreaking research; high-impact research with near-term clinical relevance; the next generation of prostate cancer investigators through mentored research; and resources that will facilitate translational research. Mechanisms include: Early Investigator Research Award; Physician Research Award; Translational Science Award; Health Disparity Research Award; Idea Development Award; Clinical Consortium Award; Data Science Award; and Health Equity Research and Outcomes Improvement Consortium (HEROIC) Award.

Varies

DOD-CDMRP Kidney Cancer Research Program (KCRP)   The KCRP’s vision is to eliminate kidney cancer through collaboration and discovery. The mission of the FY21 KCRP is to promote rigorous, innovative, high-impact research in kidney cancer for the benefit of Service Members, Veterans, and the American public. Within this context, the KCRP is interested in supporting research and clinical care that addresses the KCRP Overarching Strategic Goals to: (1) increase understanding of the biology of kidney cancer; (2) develop novel therapeutic strategies for the treatment of kidney cancer; (3) improve patient care for kidney cancer; and (4) grow the field and increase collaboration in the area of kidney cancer.   Mechanisms include: Concept Award; Idea Development Award; Postdoctoral and Clinical Fellowship Award; and Translational Research Partnership Award.

Varies

DOD-CDMRP Peer Reviewed Cancer Research Program (PRCRP)  The goal of the PRCRP is to improve quality of life by decreasing the impact of cancer on active-duty Service Members, their families, Veterans, and the American public. The PRCRP is charged by Congress with the mission to investigate cancer risks and knowledge gaps that may be relevant to active-duty Service Members, their families, other military beneficiaries, and the American public. Mechanisms include: Behavioral Health Science Award; Career Development Award – Fellow Option; Idea Award; Impact Award; and Translational team Science Award. Deadline: Varies by mechanism

Varies

Damon Runyon Cancer Research Foundation  The Damon Runyon Cancer Research Foundation, we fund high-risk, high-reward cancer research.  The foundation provides a variety of cancer-related funding opportunities. Deadline:  Varies by opportunity

Varies